LV12293A - Paratireoidala hormona analogi osteoporozes arstesanai - Google Patents

Paratireoidala hormona analogi osteoporozes arstesanai

Info

Publication number
LV12293A
LV12293A LV990015A LV990015A LV12293A LV 12293 A LV12293 A LV 12293A LV 990015 A LV990015 A LV 990015A LV 990015 A LV990015 A LV 990015A LV 12293 A LV12293 A LV 12293A
Authority
LV
Latvia
Prior art keywords
analogues
lys
activities
parathyroid hormone
rat
Prior art date
Application number
LV990015A
Other languages
English (en)
Other versions
LV12293B (en
Inventor
Jean-Rene Barbier
Paul Morley
Witold Neugebauer
Virginia Ross
James Whitfield
Gordon E Willick
Original Assignee
Ca Nat Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/691,647 external-priority patent/US5955425A/en
Application filed by Ca Nat Research Council filed Critical Ca Nat Research Council
Publication of LV12293A publication Critical patent/LV12293A/lv
Publication of LV12293B publication Critical patent/LV12293B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Measurement Of Radiation (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LVP-99-15A 1996-08-02 1999-02-01 Parathyroid hormone analogues for the treatment of osteoporosis LV12293B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/691,647 US5955425A (en) 1996-08-02 1996-08-02 Parathyroid hormone analogues for the treatment of osteoporosis
US4056097P 1997-03-14 1997-03-14
PCT/CA1997/000547 WO1998005683A1 (en) 1996-08-02 1997-08-01 Parathyroid hormone analogues for the treatment of osteoporosis

Publications (2)

Publication Number Publication Date
LV12293A true LV12293A (lv) 1999-06-20
LV12293B LV12293B (en) 2000-11-20

Family

ID=26717175

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-99-15A LV12293B (en) 1996-08-02 1999-02-01 Parathyroid hormone analogues for the treatment of osteoporosis

Country Status (24)

Country Link
EP (1) EP0915911B1 (lv)
JP (3) JP4122061B2 (lv)
KR (1) KR100500859B1 (lv)
CN (1) CN1176947C (lv)
AT (1) ATE253078T1 (lv)
AU (1) AU723728B2 (lv)
BG (1) BG103128A (lv)
BR (1) BR9711002B1 (lv)
CA (1) CA2261564C (lv)
CZ (1) CZ34799A3 (lv)
DE (1) DE69725850T2 (lv)
DK (1) DK0915911T3 (lv)
EE (1) EE9900039A (lv)
ES (1) ES2207740T3 (lv)
FI (1) FI990126L (lv)
GE (1) GEP20033095B (lv)
IS (1) IS4962A (lv)
LV (1) LV12293B (lv)
NZ (1) NZ333809A (lv)
PT (1) PT915911E (lv)
RU (1) RU2203286C2 (lv)
SI (1) SI9720057A (lv)
SK (1) SK287397B6 (lv)
WO (1) WO1998005683A1 (lv)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0003349A3 (en) * 1997-05-14 2001-12-28 Aventis Pharmaceuticals Inc Co Peptide parathyroid hormone analogs, pharmaceutical compositions comprising thereof and their use
JP4486256B2 (ja) 1998-10-22 2010-06-23 ザ・ジェネラル・ホスピタル・コーポレイション 副甲状腺ホルモン（ＰＴＨ）および副甲状腺ホルモン関連ペプチド（ＰＴＨｒＰ）の生物活性ペプチドおよびペプチド誘導体
WO2000031266A1 (en) * 1998-11-25 2000-06-02 The General Hospital Corporation Human parathyroid hormone modifications, preparation and use
ATE308609T1 (de) 1998-12-31 2005-11-15 Gen Hospital Corp Pth rezeptor und testverfahren unter verwendung desselben
AU777634B2 (en) * 1999-07-28 2004-10-28 Kazuhiro Aoki Methods of inhibiting osteoclastogenesis
US6316410B1 (en) * 1999-09-22 2001-11-13 National Research Council Of Canada Parathyroid hormone analogues for the treatment of osteoporosis
AU2002339843B2 (en) 2001-07-23 2007-12-06 The General Hospital Corporation Conformationally constrained parathyroid hormone (PTH) analogs
KR20040030120A (ko) * 2001-08-17 2004-04-08 노파르티스 아게 부갑상선 호르몬 단편의 경구 전달제로서의 5-ｃｎａｃ
EP1531855A4 (en) 2002-01-10 2009-07-22 Osteotrophin Llc TREATMENT OF BONE DISEASES WITH SKELETTAL ANABOLIKA
CA2511966A1 (en) * 2002-11-01 2004-07-22 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
US8088734B2 (en) * 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides
CN100508957C (zh) * 2003-01-21 2009-07-08 尤尼金实验室股份有限公司 肽经口输递的改进
AU2006343306A1 (en) * 2005-09-06 2007-11-15 Zelos Therapeutics, Inc. Parathyroid hormone analogues and methods of use
CA2659846A1 (en) * 2006-07-31 2008-02-07 Zelos Therapeutics, Inc. Parathyroid hormone analogues and methods of use
BRPI0719885B8 (pt) 2006-10-13 2021-05-25 Lilly Co Eli peptídeos peguilados como moduladores de receptores de pth, seus usos, e composição.
CN104072606B (zh) 2007-08-01 2017-09-22 总医院有限公司 利用g蛋白偶联受体和相关组合物的筛选方法
MX358161B (es) * 2010-05-13 2018-08-06 The General Hospital Corp Star Analogos de hormona paratiroidea y usos para los mismos.
CN105440126B (zh) * 2015-12-31 2019-10-25 南京工业大学 治疗骨质疏松的α-螺旋多肽及其制备方法与应用
US11219697B2 (en) 2017-07-15 2022-01-11 The Regents Of The University Of California Osteoadsorptive fluorogenic substrate of cathepsin k for imaging osteoclast activity and migration
US12404393B2 (en) 2018-09-26 2025-09-02 Borealis Ag Propylene copolymer composition with excellent optical and mechanical properties
CN113549144A (zh) * 2021-06-30 2021-10-26 华南理工大学 一种特立帕肽hPTH(1-34)的生产和纯化方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0532696A (ja) * 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
US5317010A (en) * 1991-10-10 1994-05-31 Peter K. T. Pang Parathyroid hormone analogues substituted at AA 25, 26, 27, and use in osteoporosis treatment
US5814603A (en) * 1992-06-12 1998-09-29 Affymax Technologies N.V. Compounds with PTH activity
US5589452A (en) * 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
AU672790B2 (en) * 1992-07-15 1996-10-17 Novartis Ag Variants of parathyroid hormone and its fragments
US5556940A (en) * 1994-06-20 1996-09-17 National Research Council Of Canada Parathyroid hormone analogues for the treatment of osteoporosis

Also Published As

Publication number Publication date
PT915911E (pt) 2004-03-31
GEP20033095B (en) 2003-10-27
ES2207740T3 (es) 2004-06-01
CN1176947C (zh) 2004-11-24
FI990126A0 (fi) 1999-01-22
WO1998005683A1 (en) 1998-02-12
SI9720057A (sl) 1999-12-31
CZ34799A3 (cs) 1999-07-14
BG103128A (bg) 2000-05-31
DE69725850T2 (de) 2004-08-19
IS4962A (is) 1999-01-29
AU723728B2 (en) 2000-09-07
FI990126A7 (fi) 1999-03-31
RU2203286C2 (ru) 2003-04-27
LV12293B (en) 2000-11-20
NZ333809A (en) 2000-07-28
ATE253078T1 (de) 2003-11-15
CN1231676A (zh) 1999-10-13
KR20000029783A (ko) 2000-05-25
JP2009057386A (ja) 2009-03-19
SK287397B6 (sk) 2010-08-09
JP2001500845A (ja) 2001-01-23
BR9711002A (pt) 2002-01-15
JP4224111B2 (ja) 2009-02-12
KR100500859B1 (ko) 2005-07-14
CA2261564A1 (en) 1998-02-12
DK0915911T3 (da) 2004-03-08
FI990126L (fi) 1999-03-31
AU3690597A (en) 1998-02-25
EE9900039A (et) 1999-08-16
DE69725850D1 (de) 2003-12-04
SK13299A3 (en) 1999-10-08
CA2261564C (en) 2007-10-30
EP0915911B1 (en) 2003-10-29
EP0915911A1 (en) 1999-05-19
JP4122061B2 (ja) 2008-07-23
BR9711002B1 (pt) 2011-09-06
JP2007254480A (ja) 2007-10-04

Similar Documents

Publication Publication Date Title
LV12293A (lv) Paratireoidala hormona analogi osteoporozes arstesanai
WO2001021643A3 (en) Parathyroid hormone analogues for the treatment of osteoporosis
Chartrel et al. Characterization of melanotropin-release-inhibiting factor (melanostatin) from frog brain: homology with human neuropeptide Y.
HUP0004560A2 (hu) Törést gyógyító PTHrP analógok
AP9901686A0 (en) Peptide parathyroid hormone analogs.
AU5567790A (en) Device for reinforcing and sustaining the cap of the rotators of a human shoulder joint
DK0946191T3 (da) Anvendelse af GLP-1-analoge og -derivater indgivet perifert til regulering af fedme
DE3682641D1 (de) Grf-analoga.
ATE377026T1 (de) Behandlung von fettleibigkeit
ATE279440T1 (de) Wachstumshormonsekretionsförderer rezeptorfamilie
ITMI912582A1 (it) Mutanti dell'ormone della crescita umano e loro impiego
ATE178073T1 (de) Superaktive analoga des wachstumshormon- releasingfaktors
ES2178393T3 (es) Utilizacion de analogos del vip en la prevencion y el tratamiento de las lesiones cerebrales en el neonato humano.
DK119391A (da) Humaninsulinanaloger
MX9707904A (es) Analogos del factor de liberacion de la hormona del crecimiento.